pCMV-FLAG LAP2 Citations (7)

Originally described in: C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.
Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J Cancer Cell. 2006 Sep . 10(3):203-14. PubMed Journal

---

Articles Citing pCMV-FLAG LAP2

Articles
Tumor necrosis factor alpha- and interleukin-1beta-dependent induction of CCL3 expression by nucleus pulposus cells promotes macrophage migration through CCR1. Wang J, Tian Y, Phillips KL, Chiverton N, Haddock G, Bunning RA, Cross AK, Shapiro IM, Le Maitre CL, Risbud MV. Arthritis Rheum. 2013 Mar;65(3):832-42. doi: 10.1002/art.37819. PubMed
Loss of sorting nexin 27 contributes to excitatory synaptic dysfunction by modulating glutamate receptor recycling in Down's syndrome. Wang X, Zhao Y, Zhang X, Badie H, Zhou Y, Mu Y, Loo LS, Cai L, Thompson RC, Yang B, Chen Y, Johnson PF, Wu C, Bu G, Mobley WC, Zhang D, Gage FH, Ranscht B, Zhang YW, Lipton SA, Hong W, Xu H. Nat Med. 2013 Apr;19(4):473-80. doi: 10.1038/nm.3117. Epub 2013 Mar 24. PubMed
An isoform of C/EBPbeta, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migration. Park BH, Kook S, Lee S, Jeong JH, Brufsky A, Lee BC. J Biol Chem. 2013 Oct 4;288(40):28656-67. doi: 10.1074/jbc.M113.509505. Epub 2013 Aug 21. PubMed
The CCAAT/enhancer-binding protein beta-2 isoform (CEBPbeta-2) upregulates galectin-7 expression in human breast cancer cells. Campion CG, Labrie M, Grosset AA, St-Pierre Y. PLoS One. 2014 May 2;9(5):e95087. doi: 10.1371/journal.pone.0095087. eCollection 2014. PubMed
miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPbeta. Zhang XF, Li KK, Gao L, Li SZ, Chen K, Zhang JB, Wang D, Tu RF, Zhang JX, Tao KX, Wang G, Zhang XD. Oncotarget. 2015 Feb 28;6(6):4144-58. PubMed
c-Myb and C/EBPbeta regulate OPN and other senescence-associated secretory phenotype factors. Flanagan KC, Alspach E, Pazolli E, Parajuli S, Ren Q, Arthur LL, Tapia R, Stewart SA. Oncotarget. 2017 Dec 5;9(1):21-36. doi: 10.18632/oncotarget.22940. eCollection 2018 Jan 2. PubMed
Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure. Ruiz-Velasco A, Zi M, Hille SS, Azam T, Kaur N, Jiang J, Nguyen B, Sekeres K, Binder P, Collins L, Pu F, Xiao H, Guan K, Frey N, Cartwright EJ, Muller OJ, Wang X, Liu W. Elife. 2020 Mar 30;9. pii: 54298. doi: 10.7554/eLife.54298. PubMed

If you have published an article using this material, please email us at to have your article added to this page.